Irinotecan therapy in adults with recurrent or progressive malignant glioma
- Author
- FRIEDMAN, H. S; PETROS, W. P; CLOUGHSEY, T; STEWART, E. S; COLVIN, O. M; PROVENZALE, J. M; MCLENDON, R. E; BIGNER, D. D; COKGOR, L; HAGLUND, M; RICH, J; ASHLEY, D; FRIEDMAN, A. H; MALCZYN, J; ELFRING, G. L; MILLER, L. L; SCHAAF, L. J; KERBY, T; LAWYER, J; PARRY, M; HOUGHTON, P. J; LOVELL, S; RASHEED, K
Department of Medicine, University of California Los Angeles School of Medicine, Los Angeles, CA, United States
Department of Molecular Pharmacology, St Jude Children's Research Hospital, Memphis, TN, United States
Departments of Surgery, Medicine, Pediatrics, Radiology, and Pathology, Duke University Medical Center, Durham, NC, United States
Pharmacia & Upjohn, Kalamazoo, MI, United States - Source
Journal of clinical oncology. 1999, Vol 17, Num 5, pp 1516-1525 ; ref : 60 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Activité biologique Anticancéreux Chimiothérapie Complication DNA topoisomerase Gliome malin Homme Inhibiteur enzyme Irinotécan Pharmacocinétique Pronostic Récidivant Toxicité Traitement Pyrano indolizino quinoléine dérivé Enzyme Isomerases Système nerveux central pathologie Système nerveux pathologie Tumeur maligne
- Keyword (en)
- Biological activity Antineoplastic agent Chemotherapy Complication DNA topoisomerase Malignant glioma Human Enzyme inhibitor Irinotecan Pharmacokinetics Prognosis Recurrent Toxicity Treatment Enzyme Isomerases Central nervous system disease Nervous system diseases Malignant tumor
- Keyword (es)
- Actividad biológica Anticanceroso Quimioterapia Complicación DNA topoisomerase Glioma maligno Hombre Inhibidor enzima Irinotecán Farmacocinética Pronóstico Recidivante Toxicidad Tratamiento Enzima Isomerases Sistema nervosio central patología Sistema nervioso patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1771710
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.1999.17.5.1516 
https://dx.doi.org/10.1200/JCO.1999.17.5.1516
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1999.17.5.1516\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1516\";s:8:\"\u0000*\u0000epage\";s:4:\"1525\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRIEDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:12:\"PETROS, W. P\";i:1;s:12:\"CLOUGHSEY, T\";i:2;s:13:\"STEWART, E. S\";i:3;s:12:\"COLVIN, O. M\";i:4;s:16:\"PROVENZALE, J. M\";i:5;s:14:\"MCLENDON, R. E\";i:6;s:12:\"BIGNER, D. D\";i:7;s:9:\"COKGOR, L\";i:8;s:10:\"HAGLUND, M\";i:9;s:7:\"RICH, J\";i:10;s:9:\"ASHLEY, D\";i:11;s:14:\"FRIEDMAN, A. H\";i:12;s:10:\"MALCZYN, J\";i:13;s:13:\"ELFRING, G. L\";i:14;s:12:\"MILLER, L. L\";i:15;s:12:\"SCHAAF, L. J\";i:16;s:8:\"KERBY, T\";i:17;s:9:\"LAWYER, J\";i:18;s:8:\"PARRY, M\";i:19;s:14:\"HOUGHTON, P. J\";i:20;s:9:\"LOVELL, S\";i:21;s:10:\"RASHEED, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1999.17.5.1516\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1516\";s:8:\"\u0000*\u0000epage\";s:4:\"1525\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRIEDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:12:\"PETROS, W. P\";i:1;s:12:\"CLOUGHSEY, T\";i:2;s:13:\"STEWART, E. S\";i:3;s:12:\"COLVIN, O. M\";i:4;s:16:\"PROVENZALE, J. M\";i:5;s:14:\"MCLENDON, R. E\";i:6;s:12:\"BIGNER, D. D\";i:7;s:9:\"COKGOR, L\";i:8;s:10:\"HAGLUND, M\";i:9;s:7:\"RICH, J\";i:10;s:9:\"ASHLEY, D\";i:11;s:14:\"FRIEDMAN, A. H\";i:12;s:10:\"MALCZYN, J\";i:13;s:13:\"ELFRING, G. L\";i:14;s:12:\"MILLER, L. L\";i:15;s:12:\"SCHAAF, L. J\";i:16;s:8:\"KERBY, T\";i:17;s:9:\"LAWYER, J\";i:18;s:8:\"PARRY, M\";i:19;s:14:\"HOUGHTON, P. J\";i:20;s:9:\"LOVELL, S\";i:21;s:10:\"RASHEED, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1999.17.5.1516\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1999.17.5.1516\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1516\";s:8:\"\u0000*\u0000epage\";s:4:\"1525\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRIEDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:12:\"PETROS, W. P\";i:1;s:12:\"CLOUGHSEY, T\";i:2;s:13:\"STEWART, E. S\";i:3;s:12:\"COLVIN, O. M\";i:4;s:16:\"PROVENZALE, J. M\";i:5;s:14:\"MCLENDON, R. E\";i:6;s:12:\"BIGNER, D. D\";i:7;s:9:\"COKGOR, L\";i:8;s:10:\"HAGLUND, M\";i:9;s:7:\"RICH, J\";i:10;s:9:\"ASHLEY, D\";i:11;s:14:\"FRIEDMAN, A. H\";i:12;s:10:\"MALCZYN, J\";i:13;s:13:\"ELFRING, G. L\";i:14;s:12:\"MILLER, L. L\";i:15;s:12:\"SCHAAF, L. J\";i:16;s:8:\"KERBY, T\";i:17;s:9:\"LAWYER, J\";i:18;s:8:\"PARRY, M\";i:19;s:14:\"HOUGHTON, P. J\";i:20;s:9:\"LOVELL, S\";i:21;s:10:\"RASHEED, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1999.17.5.1516\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1516\";s:8:\"\u0000*\u0000epage\";s:4:\"1525\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRIEDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:12:\"PETROS, W. P\";i:1;s:12:\"CLOUGHSEY, T\";i:2;s:13:\"STEWART, E. S\";i:3;s:12:\"COLVIN, O. M\";i:4;s:16:\"PROVENZALE, J. M\";i:5;s:14:\"MCLENDON, R. E\";i:6;s:12:\"BIGNER, D. D\";i:7;s:9:\"COKGOR, L\";i:8;s:10:\"HAGLUND, M\";i:9;s:7:\"RICH, J\";i:10;s:9:\"ASHLEY, D\";i:11;s:14:\"FRIEDMAN, A. H\";i:12;s:10:\"MALCZYN, J\";i:13;s:13:\"ELFRING, G. L\";i:14;s:12:\"MILLER, L. L\";i:15;s:12:\"SCHAAF, L. J\";i:16;s:8:\"KERBY, T\";i:17;s:9:\"LAWYER, J\";i:18;s:8:\"PARRY, M\";i:19;s:14:\"HOUGHTON, P. J\";i:20;s:9:\"LOVELL, S\";i:21;s:10:\"RASHEED, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1200\/JCO.1999.17.5.1516\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1516\";s:8:\"\u0000*\u0000epage\";s:4:\"1525\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRIEDMAN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"H. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:22:{i:0;s:12:\"PETROS, W. P\";i:1;s:12:\"CLOUGHSEY, T\";i:2;s:13:\"STEWART, E. S\";i:3;s:12:\"COLVIN, O. M\";i:4;s:16:\"PROVENZALE, J. M\";i:5;s:14:\"MCLENDON, R. E\";i:6;s:12:\"BIGNER, D. D\";i:7;s:9:\"COKGOR, L\";i:8;s:10:\"HAGLUND, M\";i:9;s:7:\"RICH, J\";i:10;s:9:\"ASHLEY, D\";i:11;s:14:\"FRIEDMAN, A. H\";i:12;s:10:\"MALCZYN, J\";i:13;s:13:\"ELFRING, G. L\";i:14;s:12:\"MILLER, L. L\";i:15;s:12:\"SCHAAF, L. J\";i:16;s:8:\"KERBY, T\";i:17;s:9:\"LAWYER, J\";i:18;s:8:\"PARRY, M\";i:19;s:14:\"HOUGHTON, P. J\";i:20;s:9:\"LOVELL, S\";i:21;s:10:\"RASHEED, K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Irinotecan therapy in adults with recurrent or progressive malignant glioma\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
